cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Altimmune Inc
35 own
7 watching
Current Price
$6.91
$0.02
(0.29%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
494.66M
52-Week High
52-Week High
14.84000
52-Week Low
52-Week Low
2.09000
Average Volume
Average Volume
3.58M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization494.66M
icon52-Week High14.84000
icon52-Week Low2.09000
iconAverage Volume3.58M
iconDividend Yield--
iconP/E Ratio--
What does the Altimmune Inc do?
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company s lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
Read More
How much money does Altimmune Inc make?
News & Events about Altimmune Inc.
Globe Newswire
10 months ago
GAITHERSBURG, Md., June 16, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, has been invited to participate on a Metabolic panel at the Healthcare Virtual Conference Part II...
PR Newswire
1 year ago
Thinking about buying stock in Advanced Micro Devices, BigBear.ai, Riot Platforms, Bit Digital, or Altimmune? Thinking about buying stock in Advanced Micro Devices, BigBear.ai, Riot Platforms, Bit Digital, or Altimmune? PR Newswire NEW YORK, April 18, 2023 NEW YORK, April 18, 2023 /PRNewswire...
PR Newswire
1 year ago
Thinking about buying stock in AMC Entertainment, Li Auto, Kingsoft Cloud, Altimmune, or Ford Motor? Thinking about buying stock in AMC Entertainment, Li Auto, Kingsoft Cloud, Altimmune, or Ford Motor? PR Newswire NEW YORK, April 17, 2023 NEW YORK, April 17, 2023 /PRNewswire...
Ticker Report
1 year ago
Altimmune (NASDAQ:ALT Get Rating)s stock had its market outperform rating restated by equities research analysts at JMP Securities in a research report issued on Wednesday, Benzinga reports. They currently have a $26.00 price objective on the stock. A number of other ...
Globe Newswire
1 year ago
Mr. Jordt brings over 25 years of industry experience in corporate strategy and business developmentGAITHERSBURG, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Raymond Jordt as Chief Business ...
Frequently Asked Questions
Frequently Asked Questions
What is Altimmune Inc share price today?
plus_minus_icon
Can Indians buy Altimmune Inc shares?
plus_minus_icon
How can I buy Altimmune Inc shares from India?
plus_minus_icon
Can Fractional shares of Altimmune Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Altimmune Inc stocks?
plus_minus_icon
What is today’s traded volume of Altimmune Inc?
plus_minus_icon
What is today’s market capitalisation of Altimmune Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Altimmune Inc?
plus_minus_icon
What percentage is Altimmune Inc down from its 52-Week High?
plus_minus_icon
What percentage is Altimmune Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$6.91
$0.02
(0.29%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00